Formulary

A PBM formulary is the list of prescription drugs the PBM covers under a given plan, organized into tiers that drive patient cost-sharing, prior authorization, step therapy, and quantity limit rules. Common tier structures: Tier 1 (preferred generic), Tier 2 (preferred brand or non-preferred generic), Tier 3 (non-preferred brand), Tier 4 (specialty), with some plans adding Tier 5 (preferred specialty) and Tier 6 (select preventive). Formulary placement determines patient out-of-pocket cost, prescriber documentation burden, and pharmacy reimbursement framework.

How a PBM formulary works

The PBM's Pharmacy and Therapeutics (P&T) Committee reviews drug classes and assigns formulary tier placement based on clinical evidence, cost, manufacturer rebate negotiation, and competitive market conditions. Formulary updates run on a defined schedule (typically quarterly for major changes, with mid-cycle changes available for clinical or contracting reasons). Each tier carries operational implications: prior authorization rules, step therapy rules, quantity limits, age restrictions, and prescriber-specialty restrictions vary by tier and by drug.

The pharmacy verifies formulary placement at point of sale through the PBM's claim adjudication response. The response carries the approval, denial, or message-coded conditional approval that drives the dispensing decision. Formulary-related audit findings include claims dispensed without the required prior authorization, claims dispensed for a non-formulary drug without the appropriate exception, and claims for higher-tier drugs that should have stepped through lower-tier alternatives.

When formulary rules apply

Formulary rules apply to every prescription drug claim adjudicated by the PBM. Commercial plans, Medicare Part D plans, Medicaid managed care plans, and TRICARE all operate through formulary structures, with the specific tier framework varying by plan type and contract. State drug-coverage mandates can add layers on top of the PBM-set formulary (e.g., state-mandated coverage for HIV medications, oncology, mental health) that limit the PBM's discretion to deny coverage.

The pharmacy's exposure under formulary audit findings

Per-claim recoupment exposure on formulary findings runs as the full claim reimbursement. Findings categories include: dispensing without required prior authorization, dispensing the wrong drug from the tier structure, exceeding tier-specified quantity limits, and dispensing for prescriber specialties or patient age groups outside the formulary's approval scope. Statistical extrapolation can scale individual findings substantially. The defense framework focuses on the contemporaneous formulary version in effect on the dispense date, the PBM's claim adjudication response, the prior authorization audit trail, and methodology challenge where extrapolation applies.

Related terms

• Prior authorization The PBM approval process governed by formulary tier placement.
• Step therapy The PBM utilization management rule structured through formulary tiers.
• PBM audit The audit framework that verifies formulary compliance on every sampled claim.
• DAW The NCPDP code framework that interacts with formulary tier rules in claim adjudication.

See also

• Practice area
  PBM Audit Defense

  PBM audit defense framework including formulary-related findings.

• Practice area
  Recoupment Defense

  Defense framework for formulary-driven recoupment demands.